PFAS are widespread, persistent and difficult to measure. This article explores the limitations of current detection methods ...
Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback